Table 3 Reasons for non-persistence to bisphosphonates in patients with rheumatoid arthritis
|  | Non-persistence to BPs (n = 274) |
|---|---|
Adverse events, n (%) | 130 (47.5) |
 Gastrointestinal complaint, n (%) | 112 (40.9) |
 Myalgia/arthralgia, n (%) | 9 (3.3) |
 ONJ, n (%) | 4 (1.5) |
 Kidney injury, n (%) | 3 (1.1) |
 Cardioplumonary disorder, n (%) | 2 (0.7) |
Poor healthy literacy, n (%) | 111 (40.5) |
Cost, n (%) | 33 (12) |